Tagrisso approved in China as a 1st-line treatment for EGFR-mutated non-small cell lung cancer Read more
Impel NeuroPharma Announces Last Patient Enrolled In Phase 3 Trial Evaluating INP104 For The Treatment Of Acute Migraine Read more
Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine Read more
Cidara Therapeutics and Mundipharma Form Strategic Partnership to Develop and Commercialize Rezafungin Read more